Latest News

• share
• favorite_border

• share
• favorite_border

National Italian American Foundation (NIAF) board member and Sbarro Health Research Organization (SHRO) founder Dr. Antonio Giordano congratulates Dr. Anthony Fauci on his awarding of the Leonardo da Vinci Award for Leadership in Health and Science at this year’s NIAF Anniversary Gala, held virtually on October 31st, 2020.

• share
• favorite_border

A study exploring a new combination of therapeutic agents has recently been published in the International Journal of Molecular Sciences, describing dl922-947, an oncolytic adenovirus, and AZD1775, an inhibitor of the DNA damage checkpoint kinase WEE1, and their possible efficacy to treat MPM.

• share
• favorite_border

Mesothelioma is a deadly cancer mainly caused by exposure to asbestos fibers.

• share
• favorite_border

These aspects may have important implications for the design of new drugs and therapeutic interventions for these progressive and incurable diseases.

• share
• favorite_border

Held in Locri, Italy on Saturday, August 8 in the enchanting Riviera dei Gelsomini, the Women of Talent Award ceremony recognized the achievements of Francesca Pentimalli, PhD, a frequent collaborator on research with the Sbarro Health Research Organization (SHRO).

• share
• favorite_border

Not long after the Coronavirus disease (Covid-19) outbreak in China, Italy was hard-hit by the infection and rapidly became one of the countries with the highest mortality rate.

• share
• favorite_border

Malignant mesothelioma (MM) is a lethal cancer mainly caused by exposure to asbestos, for which, unfortunately, no current treatment has proven effective, despite the identification of several promising therapeutic targets over the years.

• share
• favorite_border

A new class of anticancer agents can restore the ability of cytotoxic T lymphocytes (CTLs) to infiltrate the tumor and kill target cells in patients with metastatic non-small cell lung cancer (mNSCLC).

• share
• favorite_border

An international team of investigators has recently discovered that the receptor tyrosine-kinase EphA2 activated by the growth factor progranulin is a tumorigenic driver of bladder cancer progression.

• share
• favorite_border

• share
• favorite_border

Researchers predict the Human Leukocyte Antigen (HLA) gene has a key role in shaping immune response to COVID.

• share
• favorite_border

Silencing of the protein coding gene PRMT5 has possible therapeutic potential for treating Mesothelioma (MM), according to a recent in vitro study published in the Journal of Cellular and Molecular Medicine.

• share
• favorite_border

In Italy, a COVID-19 epidemic is raging. This analysis, which might be useful also to forecast the next epidemic trends in the U.S., is briefly recapitulated in the following document.

• share
• favorite_border

“The new virus originating from Wuhan is the third coronavirus that has made the ‘jump’ from animals to humans,” explains Enrico Bucci, Ph.D., professor and research scientist at the Sbarro Health Research Organization (SHRO), at Temple University in Philadelphia.

• share
• favorite_border

COVID-19 is similar in symptoms to the seasonal flu, but to recognize it there is a different procedure and we have to act accordingly

• share
• favorite_border

A team of investigators has recently discovered that the collagen receptor DDR1 functionally interacts with the insulin-like growth factor system in regulating bladder cancer.

• share
• favorite_border

An international team of researchers found that high BMI correlates to lower survival in patients with HER2+ metastatic breast cancer, even among patients showing initial positive response to new anti-HER2 agents pertuzumab and trastuzumab.

• share
• favorite_border

Virtual Reality during chemotherapy shown to improve breast cancer patients’ quality of life during the most stressful treatments, according to a recent study.

• share
• favorite_border

Today a team of researchers from the Department of Veterinary Medicine and Animal Production of the Federico II University of Naples, in collaboration with the Sbarro Health Research Organization (SHRO), at Temple University in Philadelphia, and the Department of Biotechnology at the University of Siena, Itay, has discovered the effectiveness of a new extract, of natural origin, able to prevent nephrotoxicity induced by the mycotoxin Ochratoxin A (OTA), and has published this research in the international Journal of Cellular Physiology.